GJA1 and Myocardial fibrosis: While no changes in cardiac dimensions or Cx43 expression and distribution were observed between control and DEP-exposed hearts, the pro-arrhythmic effects detected 3 weeks post-instillation were associated, in our study, with a moderate but significant increase in myocardial fibrosis.